JP2004041218A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004041218A5 JP2004041218A5 JP2003293651A JP2003293651A JP2004041218A5 JP 2004041218 A5 JP2004041218 A5 JP 2004041218A5 JP 2003293651 A JP2003293651 A JP 2003293651A JP 2003293651 A JP2003293651 A JP 2003293651A JP 2004041218 A5 JP2004041218 A5 JP 2004041218A5
- Authority
- JP
- Japan
- Prior art keywords
- polypeptide
- nucleic acid
- amino acid
- nucleotide sequence
- mitogen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 42
- 229920001184 polypeptide Polymers 0.000 claims description 41
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 41
- 210000004027 cell Anatomy 0.000 claims description 26
- 210000003027 ear inner Anatomy 0.000 claims description 12
- 239000003226 mitogen Substances 0.000 claims description 12
- 230000035755 proliferation Effects 0.000 claims description 7
- 210000002266 hair cells auditory Anatomy 0.000 claims description 3
- 206010011878 Deafness Diseases 0.000 claims description 2
- 230000010370 hearing loss Effects 0.000 claims description 2
- 231100000888 hearing loss Toxicity 0.000 claims description 2
- 208000016354 hearing loss disease Diseases 0.000 claims description 2
- 230000008929 regeneration Effects 0.000 claims description 2
- 238000011069 regeneration method Methods 0.000 claims description 2
- 108020004707 nucleic acids Proteins 0.000 claims 32
- 102000039446 nucleic acids Human genes 0.000 claims 32
- 150000007523 nucleic acids Chemical class 0.000 claims 32
- 125000003275 alpha amino acid group Chemical group 0.000 claims 17
- 239000002773 nucleotide Substances 0.000 claims 15
- 125000003729 nucleotide group Chemical group 0.000 claims 15
- 210000002950 fibroblast Anatomy 0.000 claims 11
- 230000004663 cell proliferation Effects 0.000 claims 5
- 230000000295 complement effect Effects 0.000 claims 5
- 108091026890 Coding region Proteins 0.000 claims 4
- 238000007792 addition Methods 0.000 claims 4
- 150000001413 amino acids Chemical class 0.000 claims 4
- 238000012217 deletion Methods 0.000 claims 4
- 230000037430 deletion Effects 0.000 claims 4
- 238000006467 substitution reaction Methods 0.000 claims 4
- 239000008194 pharmaceutical composition Substances 0.000 claims 3
- 108020004414 DNA Proteins 0.000 claims 2
- 108010076504 Protein Sorting Signals Proteins 0.000 claims 2
- 230000001939 inductive effect Effects 0.000 claims 2
- 241000588724 Escherichia coli Species 0.000 claims 1
- 108060003951 Immunoglobulin Proteins 0.000 claims 1
- 239000006143 cell culture medium Substances 0.000 claims 1
- 210000004978 chinese hamster ovary cell Anatomy 0.000 claims 1
- 238000012258 culturing Methods 0.000 claims 1
- 102000018358 immunoglobulin Human genes 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 210000005253 yeast cell Anatomy 0.000 claims 1
- 238000003556 assay Methods 0.000 description 5
- 239000002609 medium Substances 0.000 description 4
- 238000011534 incubation Methods 0.000 description 2
- 241000124008 Mammalia Species 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 230000003325 follicular Effects 0.000 description 1
- 210000000185 follicular epithelial cell Anatomy 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 239000012679 serum free medium Substances 0.000 description 1
- 229940104230 thymidine Drugs 0.000 description 1
Applications Claiming Priority (10)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11314598P | 1998-12-16 | 1998-12-16 | |
| US11285198P | 1998-12-16 | 1998-12-16 | |
| US11351198P | 1998-12-22 | 1998-12-22 | |
| US11555899P | 1999-01-12 | 1999-01-12 | |
| US11556599P | 1999-01-12 | 1999-01-12 | |
| US11573399P | 1999-01-12 | 1999-01-12 | |
| US11934199P | 1999-02-09 | 1999-02-09 | |
| US11953799P | 1999-02-10 | 1999-02-10 | |
| US11996599P | 1999-02-12 | 1999-02-12 | |
| PCT/US1999/012252 WO1999063088A2 (en) | 1998-06-02 | 1999-06-02 | Membrane-bound proteins and nucleic acids encoding the same |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000588351A Division JP2003521229A (ja) | 1998-12-16 | 1999-12-01 | 分泌及び膜貫通ポリペプチドとそれをコードする核酸 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004041218A JP2004041218A (ja) | 2004-02-12 |
| JP2004041218A5 true JP2004041218A5 (https=) | 2007-04-05 |
Family
ID=27578476
Family Applications (5)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000588351A Withdrawn JP2003521229A (ja) | 1998-12-16 | 1999-12-01 | 分泌及び膜貫通ポリペプチドとそれをコードする核酸 |
| JP2003293651A Withdrawn JP2004041218A (ja) | 1998-12-16 | 2003-08-14 | 分泌ポリペプチドとそれをコードする核酸 |
| JP2003293650A Withdrawn JP2004041217A (ja) | 1998-12-16 | 2003-08-14 | 分泌及び膜貫通ポリペプチドとそれをコードする核酸 |
| JP2006282251A Withdrawn JP2007075118A (ja) | 1998-12-16 | 2006-10-17 | 分泌及び膜貫通ポリペプチドとそれをコードする核酸 |
| JP2007156006A Withdrawn JP2007312779A (ja) | 1998-12-16 | 2007-06-13 | 分泌及び膜貫通ポリペプチドとそれをコードする核酸 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000588351A Withdrawn JP2003521229A (ja) | 1998-12-16 | 1999-12-01 | 分泌及び膜貫通ポリペプチドとそれをコードする核酸 |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003293650A Withdrawn JP2004041217A (ja) | 1998-12-16 | 2003-08-14 | 分泌及び膜貫通ポリペプチドとそれをコードする核酸 |
| JP2006282251A Withdrawn JP2007075118A (ja) | 1998-12-16 | 2006-10-17 | 分泌及び膜貫通ポリペプチドとそれをコードする核酸 |
| JP2007156006A Withdrawn JP2007312779A (ja) | 1998-12-16 | 2007-06-13 | 分泌及び膜貫通ポリペプチドとそれをコードする核酸 |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP1141285A2 (https=) |
| JP (5) | JP2003521229A (https=) |
| KR (2) | KR100468978B1 (https=) |
| AU (7) | AU777006B2 (https=) |
| CA (1) | CA2348757A1 (https=) |
| IL (11) | IL142794A0 (https=) |
| MX (1) | MXPA01006057A (https=) |
| WO (1) | WO2000036102A2 (https=) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20020137890A1 (en) | 1997-03-31 | 2002-09-26 | Genentech, Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| US7192589B2 (en) | 1998-09-16 | 2007-03-20 | Genentech, Inc. | Treatment of inflammatory disorders with STIgMA immunoadhesins |
| US7419663B2 (en) | 1998-03-20 | 2008-09-02 | Genentech, Inc. | Treatment of complement-associated disorders |
| US8007798B2 (en) | 1997-11-21 | 2011-08-30 | Genentech, Inc. | Treatment of complement-associated disorders |
| US8088386B2 (en) | 1998-03-20 | 2012-01-03 | Genentech, Inc. | Treatment of complement-associated disorders |
| US6914130B2 (en) * | 1998-06-17 | 2005-07-05 | Genentech, Inc. | Compositions and methods for the diagnosis and treatment of tumor |
| AU2008201101B2 (en) * | 1999-03-11 | 2011-01-20 | Merck Serono Sa | Vascular adhesion molecules and modulation of their function |
| JP4836329B2 (ja) * | 1999-03-11 | 2011-12-14 | メルク セローノ エス．エイ． | 血管接着分子およびその機能の調節 |
| KR100543857B1 (ko) * | 1999-09-01 | 2006-01-23 | 제넨테크, 인크. | 혈관신생 및 심혈관형성의 촉진 또는 억제 |
| DE19947010A1 (de) * | 1999-09-30 | 2001-04-05 | Universitaetsklinikum Freiburg | Das Gen PRV-1 und dessen Verwendung |
| AU2001259191A1 (en) * | 2000-04-28 | 2001-11-12 | Millennium Pharmaceuticals, Inc. | 25692, a novel human o-methyltransferase family member and uses thereof |
| GB0110273D0 (en) * | 2001-04-26 | 2001-06-20 | Inpharmatica Ltd | Novel proteins |
| NZ533736A (en) * | 2001-12-19 | 2006-09-29 | Genentech Inc | Compositions and methods for the diagnosis and treatment of tumor and inhibiting cell growth |
| US20070191402A1 (en) * | 2002-05-17 | 2007-08-16 | Kyowa Hakko Kogyo Co., Ltd. | Method of searching substrate having antidiabetic activity |
| AU2003276039A1 (en) * | 2002-10-02 | 2004-04-23 | Develogen Aktiengesellschaft Fur Entwicklungsbiologische Forschung | Mipp1 homologous nucleic acids and proteins involved in the regulation of energy homeostatis |
| SG10201804008UA (en) | 2005-11-04 | 2018-06-28 | Genentech Inc | Use of complement pathway inhibitors to treat ocular diseases |
| CA2663243A1 (en) | 2006-09-28 | 2008-04-03 | Merck Serono S.A. | Junctional adhesion molecule-c (jam-c) binding compounds and methods of their use |
| TW201716437A (zh) | 2006-11-02 | 2017-05-16 | 建南德克公司 | 人類化之抗-因子ｄ抗體及其用途 |
| AR066660A1 (es) | 2007-05-23 | 2009-09-02 | Genentech Inc | Prevencion y tratamiento de condiciones del ojo asociadas con su complemento |
| CR20170001A (es) | 2008-04-28 | 2017-08-10 | Genentech Inc | Anticuerpos anti factor d humanizados |
| SG190596A1 (en) | 2008-05-06 | 2013-06-28 | Genentech Inc | Affinity matured crig variants |
| SG11201601044XA (en) | 2013-08-12 | 2016-03-30 | Genentech Inc | Compositions and method for treating complement-associated conditions |
| AU2015253042A1 (en) | 2014-05-01 | 2016-10-20 | Genentech, Inc. | Anti-factor D antibody variants and uses thereof |
| EP3368090A1 (en) | 2015-10-30 | 2018-09-05 | H. Hoffnabb-La Roche Ag | Anti-factor d antibody variant conjugates and uses thereof |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0791009A4 (en) * | 1994-11-07 | 2003-03-05 | Merck & Co Inc | Modified neuropeptide y receptors |
| AU1532697A (en) * | 1996-01-12 | 1997-08-01 | Genetics Institute Inc. | Beta-chemokine, h1305 (mcp-2) |
| CA2289118A1 (en) * | 1997-05-06 | 1998-11-12 | Zymogenetics, Inc. | Novel tumor antigens |
| DE19818620A1 (de) * | 1998-04-21 | 1999-10-28 | Metagen Gesellschaft Fuer Genomforschung Mbh | Menschliche Nukleinsäuresequenzen aus Blase-Normal |
| WO2000000610A2 (en) * | 1998-06-26 | 2000-01-06 | Incyte Pharmaceuticals, Inc. | Human signal peptide-containing proteins |
| WO2000004135A2 (en) * | 1998-07-16 | 2000-01-27 | Incyte Pharmaceuticals, Inc. | Human scad-related molecules, scrm-1 and scrm-2 |
| DE19849044A1 (de) * | 1998-10-23 | 2000-04-27 | Univ Ludwigs Albert | Das Gen PRV-1 und dessen Verwendung |
| AU1631000A (en) * | 1998-11-19 | 2000-06-05 | Incyte Pharmaceuticals, Inc. | Immunoglobulin superfamily proteins |
| PT1626058E (pt) * | 1999-03-08 | 2008-02-15 | Genentech Inc | Composições e métodos para o diagnóstico de tumores |
-
1999
- 1999-12-01 CA CA002348757A patent/CA2348757A1/en not_active Abandoned
- 1999-12-01 JP JP2000588351A patent/JP2003521229A/ja not_active Withdrawn
- 1999-12-01 WO PCT/US1999/028634 patent/WO2000036102A2/en not_active Ceased
- 1999-12-01 KR KR10-2001-7007461A patent/KR100468978B1/ko not_active Expired - Fee Related
- 1999-12-01 EP EP99962992A patent/EP1141285A2/en not_active Withdrawn
- 1999-12-01 MX MXPA01006057A patent/MXPA01006057A/es active IP Right Grant
- 1999-12-01 AU AU19320/00A patent/AU777006B2/en not_active Expired
- 1999-12-01 IL IL14279499A patent/IL142794A0/xx active IP Right Grant
- 1999-12-01 KR KR10-2004-7013508A patent/KR100468977B1/ko not_active Expired - Fee Related
-
2001
- 2001-04-25 IL IL142794A patent/IL142794A/en not_active IP Right Cessation
-
2003
- 2003-08-14 JP JP2003293651A patent/JP2004041218A/ja not_active Withdrawn
- 2003-08-14 JP JP2003293650A patent/JP2004041217A/ja not_active Withdrawn
-
2004
- 2004-12-10 AU AU2004237842A patent/AU2004237842B2/en not_active Expired
- 2004-12-14 AU AU2004237920A patent/AU2004237920B2/en not_active Expired
- 2004-12-14 AU AU2004237921A patent/AU2004237921B2/en not_active Expired
- 2004-12-14 AU AU2004237922A patent/AU2004237922B2/en not_active Expired
- 2004-12-14 AU AU2004237919A patent/AU2004237919B2/en not_active Expired
- 2004-12-14 AU AU2004237923A patent/AU2004237923B2/en not_active Expired
-
2006
- 2006-10-17 JP JP2006282251A patent/JP2007075118A/ja not_active Withdrawn
-
2007
- 2007-06-13 JP JP2007156006A patent/JP2007312779A/ja not_active Withdrawn
-
2008
- 2008-01-03 IL IL188579A patent/IL188579A0/en unknown
- 2008-01-03 IL IL188578A patent/IL188578A0/en unknown
- 2008-01-03 IL IL188577A patent/IL188577A0/en unknown
- 2008-01-03 IL IL188580A patent/IL188580A0/en unknown
- 2008-01-03 IL IL188576A patent/IL188576A0/en unknown
- 2008-01-03 IL IL188581A patent/IL188581A0/en unknown
-
2009
- 2009-09-13 IL IL200883A patent/IL200883A0/en unknown
- 2009-09-17 IL IL201001A patent/IL201001A0/en unknown
- 2009-09-17 IL IL201030A patent/IL201030A0/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2004041218A5 (https=) | ||
| JP2003532365A5 (https=) | ||
| JP2005516613A5 (https=) | ||
| JP2005046146A5 (https=) | ||
| CA2378871A1 (en) | Design of beta-sheet proteins with specific binding properties | |
| WO1991018101A1 (en) | Process for producing protein | |
| WO2025241381A1 (zh) | 一种能表达外源蛋白的菌株、重组人源胶原蛋白及合成方法与应用 | |
| RU2007124369A (ru) | Производство белков | |
| JP2001008697A (ja) | Ｅ．コリでの非融合タンパク質の調製方法 | |
| RU2230116C2 (ru) | ВЕКТОР ДЛЯ ЭКСПРЕСИИ И СЕКРЕЦИИ ЧЕЛОВЕЧЕСКОГО ИНТЕРФЕРОНА АЛЬФА(HIFNα), ШТАММ ESCHERICHIA COLI ДЛЯ ЭКСПРЕССИИ И СЕКРЕЦИИ HIFNα(ВАРИАНТЫ) И СПОСОБ ПРОДУЦИРОВАНИЯ HIFNα | |
| WO1997008312B1 (en) | Human jtv1 gene overlaps pms2 gene | |
| JP2004532037A5 (https=) | ||
| JP2000504561A (ja) | Ｉｌ―１６活性のあるポリペプチド類、その製造方法およびその使用 | |
| CN115992103A (zh) | 酶突变体及类蛇毒三肽的制备方法 | |
| US9157085B2 (en) | Expression vector for expression of eukaryotic secretion leader sequence fused with a target polypeptide and methods of use thereof | |
| JPS6037990A (ja) | Ｇｒｆ前駆体をコードするｄｎａ | |
| WO2000020439A1 (fr) | Procede d'elimination de methionine n-terminale | |
| JPS62270599A (ja) | インターフェロンにより誘導されるヒト蛋白質に対するモノクローナル抗体 | |
| JP7800891B2 (ja) | タンパク質生成に対するキメラシグナルペプチド | |
| WO1986003779A1 (fr) | Vecteur de secretion de polypeptides, micro-organismes transformes par ledit vecteur, et procede de preparation de polypeptides avec lesdits micro-organismes | |
| JP2004512009A5 (https=) | ||
| JPH1175879A (ja) | プロテインジスルフィドイソメラーゼを含有する融合タンパク質をコードするｄｎａ | |
| WO2020133610A1 (zh) | 一种重组大肠杆菌质周腔内生产唾液酸修饰n-糖基化重组蛋白方法 | |
| US5304471A (en) | Process for producing foreign protein in Escherichia coli | |
| CN101985466A (zh) | Mbd重组蛋白及其表达方法 |